VALIDATION OF RAW MATERIALS

Size: px
Start display at page:

Download "VALIDATION OF RAW MATERIALS"

Transcription

1 Seminar On VALIDATION OF RAW MATERIALS By S.Rajesh kumar M.Pharmacy I SEM Department of Industrial pharmacy University college of pharmaceutical sciences Kakatiya university

2 CONTENTS INTRODUCTION TO VALIDATION DEFINITION OF VALIDATION QUALITY ATTRIBUTES WHY TO VALIDATE WHEN TO VALIDATE DEFINITION OF RAW MATERIAL STEPS INVOLVED IN RAW MATERIAL VALIDATION CONCLUSION REFERENCES

3 VALIDATION Validation is the scientific study of a system To prove that the facility/system/equipment/method is consistently doing what it is supposed to do (i.e., that the process is under control). We want to make decisions based on good science and not hunches and assumptions! To determine the process variables and acceptable limits for these variables, and to set-up appropriate in-process controls. 1

4 FDA DEFINITION OF VALIDATION Validation is a process of demonstrating, through documented evidence, that a process, procedure, method, piece of equipment, or facility will consistently produce a product or result that meets predetermined specifications and quality attributes. 2

5 Quality Attributes Identity Safety Potency Purity Stability Efficacy 3

6 Why validate? It is required by the current good manufacturing practice(cgmp) regulations promulgated by the US FDA. It should be performed because it is in accord with good business judgment. 4

7 WHEN A PROCESS SHOULD BE VALIDATED The following model may be useful in determining whether or not a process should validated: A Is Process Output Verifiable YES B Is Verification Sufficient & Cost Effective YES C Verify & Control the Process NO NO D Validate E Redesign Product and/or Process 5

8 DEFINITION OF RAW MATERIAL RAW MATERIAL: It is a term used to denote starting materials, reagents and solvents intended for use in the production of intermediates or active pharmaceutical ingredient(api). 6

9 RAW MATERIAL VALIDATION Several steps are required to validate a raw material. They are as follows: (I) LIST ALL THE RAW MATERIALS NEEDED TO PREPARE A PRODUCT BATCH. The list should include the materials used in production and testing Active ingredients Excipients Processing aids Chemicals Official standards Laboratory materials 7

10 (II) IDENTIFY AT LEAST TWO SUPPLIERS FOR EACH RAW MATERIAL. After we have complete list of all raw materials needed, we must locate sources of these materials. It is always advisable to locate and validate at least two suppliers. EVALUATION FOR SELECTING A SUPPLIER: (1)Provide the raw material that we need (2)Must be capable of providing the grade that we want (3)Providing the quantity that we require (4)To provide increased quantities quickly (to evaluate the supplier s capacity) (5)Determine whether our supplier is a manufacturer or distributor? 8

11 (6) Cost of the raw material. (7) Reputation and reliability of the supplier. NOTE: He must use written standard operating procedures and establish proper raw material storage conditions and distribution procedures. Precautions Joint agreements Attention Investigation 9

12 (III) IF A SUPPLIER IS NEW, VISIT HIS FACILITY. It is important to establish a good relationship with a supplier. To meet representatives personally. Inspect his facility. 10

13 During the visit, it is also important to observe.. housekeeping and sanitation practiced The use of written procedures and logs proper segregation and batch identification The use of laboratory notebooks The size of the laboratory area and staff The use of up to date laboratory instrumentation production equipment. and 11

14 (IV) OBTAIN SAMPLES AND SUPPLIER S CERTIFICATES OF ANALYSIS To determine the characteristics of the raw material. The certificates of analysis and samples the extent of variation from lot to lot on specific tests. It is important to measure this variation between different lots from the same supplier and then the variation between suppliers. 12

15 (V) ESTABLISH SPECIFICATIONS FOR EACH RAW MATERIAL List of parameters. For each parameter listed, an acceptable, measurable range of activity should be established. Compendial raw materials And non- compendial raw materials 13

16 (VI) ESTABLISH TEST PROCEDURES. A test procedure must be established for each specification. For raw materials that are compendial, test procedures are denoted along with their respective specifications. For raw materials that are not listed in official compendia,we embark into methods development. This work calls on compendial methods that exist for similar compounds, which can be modified. It also calls for methods that are published literature. Documentation of so developed test procedures should be paid attention. 14

17 (VII) ESTABLISH SAMPLING PROCEDURES. Documentation of raw material sampling is developed. This procedure includes general requirements that may apply to any raw material received in the plant, such as The number of containers to sample(sample size). Method of sampling. Individual raw materials may have certain sampling requirements based on their stability and/or intended use. Before these individual sampling procedures are instituted in routine practice, they should be evaluated as part of process validation. 15

18 (VIII) ESTABLISH OPTIMUM STORAGE CONDITIONS Raw material containers must be handled and stored under prescribed conditions in order to protect their stability over the stated shelf life. The chemistry of each raw material should be reviewed and aspects concerning hygroscopity, sensitivity to light,sensitivity to high and low temperature extremes, ability to support microbial growth,reactivity with any container or closure system, and oxidising capability are checked. Once we have established the factors that critically affect a raw material, we can conduct stability studies that will indicate the optimum storage conditions and establish a shelf life for the raw material. 16

19 (IX) ESTABLISH SHELF LIFE Shelf life or expiry dating of a raw material is the time period within which it must be used. Some times we assign an expiry date that is shorter than our data indicate, so that we will always use fresh raw materials. The shelf life of a raw material is established by testing over time in the containers and closures to be used, after storage under the anticipated optimum conditions, and also under adverse conditions. 17

20 (X) CHALLENGE OF THE RAW MATERIALS. The last step required to validate a raw material is the operation in which the information that has been established concerning the raw material is challenged, to assure that is scientifically sound and meaningful. 18

21 CONCLUSION To build up quality in the final product a thorough control over each step of the process is required. This makes it essential to establish a documented evidence to be developed by thorough experimentation. So the raw materials are not an exception to this and they should be validated by opting an systematic approach. 19

22 REFERENCES Robert A. Nash, pharmaceutical process validation. Berry, I.R.,and Daniel harpaz, validation of active pharmaceutical ingredients. P.P.sharma, how to practice GMP S. Validation in API manufacturing plants.brussels:active pharmaceutical ingredients committee. Guide to Inspections Validation of Processes. Washington DC:use Food and Drug Administration. Validation of compendia Methods.The United States Pharmacopeia Convention,Inc.,

23

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union Ref. Ares(2014)968036-28/03/2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, 28 March 2014 EudraLex

More information

Regulatory. Supplier Qualification A Review

Regulatory. Supplier Qualification A Review Supplier Qualification A Review Abstract: It is a GMP requirement to certify the vendor to deliver high quality and safe medicines, and to prevent recalls, deaths, adverse events, and serious illness due

More information

QUALITY AGREEMENT. The following Agreement has been concluded between

QUALITY AGREEMENT. The following Agreement has been concluded between QUALITY AGREEMENT The following Agreement has been concluded between LLC LABORATORIES The contract laboratory and service provider 1625 Trinity Dr., Unit 11 Mississauga, Ontario Canada L5T 1W9 Hereinafter

More information

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit. FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis

More information

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines

More information

PHARMACEUTICAL TESTING

PHARMACEUTICAL TESTING WHITEHOUSE, NJ PHARMACEUTICAL TESTING Pharmaceutical Expertise for GMP & CMC Testing Our Pharmaceutical Expertise With more than 20 years of experience in a variety of industries, our Whitehouse, New Jersey

More information

Industry Perspective on Manufacturing in Early Development

Industry Perspective on Manufacturing in Early Development Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical

More information

REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG

REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG SCHEDULE Form 1 REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG THE REGISTRAR PHARAMCY BOARD MINISTRY OF HEALTH AND QUALITY OF LIFE MAURITIUS Fax: Telephone: TYPE OF APPLICATION HUMAN, BIOLOGICAL

More information

LABORATORY COMPLIANCE

LABORATORY COMPLIANCE 1 LABORATORY COMPLIANCE Jeanne Moldenhauer Vectech Pharmaceutical Consultants, Inc. Farmington Hills, MI INTRODUCTION Implementation of the Systems-Based Inspection Guideline for drug manufacturers in

More information

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Review Article Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Chagi Venkatesh*, S. B. Puranik ABSTRACT Good practices in quality control (QC) department

More information

API Testing Requirements to Support the EI Risk Assessment. Elisabeth Corbett Associate Director, GRS-CMC, Bristol-Myers Squibb November 9, 2016

API Testing Requirements to Support the EI Risk Assessment. Elisabeth Corbett Associate Director, GRS-CMC, Bristol-Myers Squibb November 9, 2016 API Testing Requirements to Support the EI Risk Assessment Elisabeth Corbett Associate Director, GRS-CMC, Bristol-Myers Squibb November 9, 2016 Agenda Background Review of ICH Q3D Risk Assessment Principles

More information

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A Stability Studies 1. If potency over time studies are not acceptable to extend BUD, then why is it offered? Potency point-in-time studies only indicate the potency of a compounded preparation at that specific

More information

Guidelines for Process Validation of Pharmaceutical Dosage Forms

Guidelines for Process Validation of Pharmaceutical Dosage Forms Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical

More information

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A Stability Studies 1. If potency over time studies are not acceptable to extend BUD, then why is it offered? Potency point-in-time studies only indicate the potency of a compounded preparation at that specific

More information

RECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS

RECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS RECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS Facilities that manufacture 117, pack, or hold dietary supplements are subject to the regulations in 21 CFR Part 111, while those that manufacture, pack,

More information

FDA Process Validation

FDA Process Validation Page 1 of 5 Published on Controlled Environments Magazine (http://www.cemag.us) Home > FDA Process Validation FDA Process Validation Wai Wong Working with the New 2011 Guidelines. In January 2011, the

More information

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation

More information

Quality of raw materials and manufacturing of advanced therapies. Fouad Atouf, Ph.D. Head, Global Biologics July 12, 2018

Quality of raw materials and manufacturing of advanced therapies. Fouad Atouf, Ph.D. Head, Global Biologics July 12, 2018 Quality of raw materials and manufacturing of advanced therapies Fouad Atouf, Ph.D. Head, Global Biologics July 12, 2018 Evolution of the compendia 1820: a single recipe book 2018: Procedures and acceptance

More information

Manual 058 Out of Specification Results Investigation

Manual 058 Out of Specification Results Investigation 1 Purpose The purpose of this Guideline is to provide guidance for the investigation and response to Out of Specification (OOS) laboratory test results. 2 Scope and Applicability This Guideline applies

More information

What s the fuss with compounding. Fuss [2] Pharmaceutical Compounding. Pharmaceutical Compounding: Learning Objectives

What s the fuss with compounding. Fuss [2] Pharmaceutical Compounding. Pharmaceutical Compounding: Learning Objectives Pharmaceutical Compounding Legal Requirements and Good Compounding Practices Tom Hazlet Autumn 2005 Pharmaceutical Compounding: Learning Objectives Describe the historical precedents and incidents that

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. This document is for consultation until 11 December 2015

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. This document is for consultation until 11 December 2015 Ref. Ares(2015)3808922-15/09/2015 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, [date] This document is for consultation until 11

More information

Validation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness

Validation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness Validation/Verification of Test Methods An FDA Perspective Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness FD & C Act Overview Definition of drugs What cgmps are Finished Pharmaceuticals cgmp

More information

21CFR Ventilation, air filtration, air heating and cooling. 21CFR211 Details, Details. 21CFR Equipment Cleaning and Maintenance

21CFR Ventilation, air filtration, air heating and cooling. 21CFR211 Details, Details. 21CFR Equipment Cleaning and Maintenance 21CFR211 Details, Details Kirsten L. Vadheim, Ph.D., RAC 7710 196th Avenue N.E. Redmond WA 98053 Tel: 651.260.6560 Fax: 425.868.4302 klvadheim@hotmail.com 21CFR211.46 Ventilation, air filtration, air heating

More information

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and

More information

Excipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance

Excipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance Excipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance by Tom Savage, NSF International Since 2008, when patient deaths were first linked to

More information

VALIDATION OF ACTIVE PHARMACEUTICAL INGREDIENTS

VALIDATION OF ACTIVE PHARMACEUTICAL INGREDIENTS VALIDATION OF ACTIVE PHARMACEUTICAL INGREDIENTS Second Edition Ira R. Berry Daniel Harpaz Editors ###5 Health Group *> MS-GHOUF Company Your Enterprise Solution for Global Healthcare Knowledge Denver,

More information

Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C.

Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Manufacturing Breakout Session 1 Survey Results: Drug Product Manufacturing

More information

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES 1640 á1224ñ Transfer of Analytical Procedures / General Information USP 39 THE ANALYTICAL PROCEDURE The procedure should be written with sufficient detail and explicit instructions, so that a trained analyst

More information

PURITAN PRODUCTS QUALITY OVERVIEW. Quality Management System Self-Audit. September 15, 2015

PURITAN PRODUCTS QUALITY OVERVIEW. Quality Management System Self-Audit. September 15, 2015 PURITAN PRODUCTS QUALITY OVERVIEW Quality Management System Self-Audit September 15, 2015 Founded in 1987, Puritan Products, Inc. is a cgmp compliant, FDA registered and inspected, and ISO-9001:2008 certified

More information

EudraLex. Part I1 Chapter 6: Quality Control

EudraLex. Part I1 Chapter 6: Quality Control EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines tofor Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use Part I1 Chapter 6: Quality

More information

BATCH DISPOSITION BATCH DISPOSITION REGULATION. Jakarta 14 DECEMBER Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT

BATCH DISPOSITION BATCH DISPOSITION REGULATION. Jakarta 14 DECEMBER Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT BATCH DISPOSITION REGULATION Jakarta 14 DECEMBER 2017 Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT Definition Batch disposition = product disposition = lot disposition The documented control, status

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer PART 1: GENERAL INFORMATION Name of Manufacturer Calyx Chemicals & Pharmaceuticals Ltd Unit:

More information

INVESTIGATE OOT AND OOS IN STABILITY STUDIES

INVESTIGATE OOT AND OOS IN STABILITY STUDIES INVESTIGATE OOT AND OOS IN STABILITY STUDIES Kim Huynh-Ba Executive Director Pharmalytik LLC www.pharmalytik.com BIOGRAPHY Kim Huynh-Ba has over 25 years of experience in analytical development, project

More information

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 047-1 Annex 1 July 2018 GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL

More information

Cleaning and Cleaning Validation of API Plant and Equipment

Cleaning and Cleaning Validation of API Plant and Equipment Regulatory Basis: FDA Quality Systems Regulations Reference: FDA CFR - Code of Federal Regulations Title 21 1 Purpose The purpose of this guideline is: To define the requirements for cleaning plant and

More information

Good Manufacturing Practice ( GMP ) Compliance: GMPs EXPLAINED

Good Manufacturing Practice ( GMP ) Compliance: GMPs EXPLAINED Good Manufacturing Practice ( GMP ) Compliance: GMPs EXPLAINED Presented by Raymond A. Bonner Nathan C. Sheers SIDLEY AUSTIN BROWN & WOOD, LLP Washington, D.C. (202) 736-8000 To The Fourth Annual Pharmaceutical

More information

While the recognition

While the recognition Designing the Perfect Change Control System Change control systems today are expected to be designed in a way that provides a system to not only document and approve changes, but also to anticipate change

More information

Reference Standard Characterization. Steve Lane. General Manager, NSF Reference Standards.

Reference Standard Characterization. Steve Lane. General Manager, NSF Reference Standards. Reference Standard Characterization Steve Lane General Manager, NSF Reference Standards www.nsf-rs.org Regulatory Bodies will require that an Excipient: Be safe in the amount or dose used Meet applicable

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

LEGAL REQUIREMENTS FOR STABILITY

LEGAL REQUIREMENTS FOR STABILITY BY DR. A.V.PRABHU LEGAL REQUIREMENTS FOR STABILITY 21 CFR 211.166- STABILITY TESTING GMP To assess stability characteristics to determine storage conditions and expiration dates. Written stability program

More information

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:

More information

Post-Approval Change Regulations in Japan

Post-Approval Change Regulations in Japan Post-Approval Change Regulations in Japan Pharmaceuticals and Medical Devices Agency Office of Cellular and Tissue-based Products Futaba Honda, Ph.D. Agenda Application Forms and attached documents for

More information

Regulatory Perspective on Assuring Ingredient Quality

Regulatory Perspective on Assuring Ingredient Quality Regulatory Perspective on Assuring Ingredient Quality PQRI Conference December 15, 2009 Rockville, MD Steven M. Wolfgang, Ph.D., Acting Associate Director, Regulatory Science US Food and Drug Administration

More information

EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems. Jan Thomsen Warsaw, November 15 th, 2016

EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems. Jan Thomsen Warsaw, November 15 th, 2016 EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems Jan Thomsen Warsaw, November 15 th, 2016 2 Content Emprove - An Introduction Emprove for Raw and Starting Materials

More information

Contents. 1. Administrative Organizations and Affairs under Jurisdiction for Veterinary Medical Devices

Contents. 1. Administrative Organizations and Affairs under Jurisdiction for Veterinary Medical Devices Assurance System of Quality, Performance, and Safety of Veterinary Medical Devices Based on the Law for Ensuring the Quality, Efficacy, and Safety of Drugs and Medical Devices Animal Products Safety Division

More information

Application of Quality by Design (QbD) in product development. James E. Polli September 16, 2015

Application of Quality by Design (QbD) in product development. James E. Polli September 16, 2015 Application of Quality by Design (QbD) in product development James E. Polli jpolli@rx.umaryland.edu September 16, 2015 Pharmaceutical Equivalence Same active ingredient(s) Same dosage form Same route

More information

How do you know the drug you are using is safe and effective?

How do you know the drug you are using is safe and effective? The Chemistry, Manufacturing, and Controls (CMC) Technical Section: The Big Picture of a Long-term Commitment AAVPT Workshop February 28, 2011 James K. Nitao, Ph.D. Biotherapeutics Team Division of Manufacturing

More information

GUIDELINE FOR THE STABILITY TESTING

GUIDELINE FOR THE STABILITY TESTING 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 GUIDELINE FOR THE STABILITY TESTING OF NON-PRESCRIPTION (OTC)

More information

Table of Contents. Legal Notices... 61

Table of Contents. Legal Notices... 61 Notice This manual provides information to excipient manufacturers who intend to participate in the United States Pharmacopeia Ingredient Verification Program for Excipients (USP IVP-E or Program). The

More information

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active

More information

Question-based Review (QbR)

Question-based Review (QbR) Question-based Review (QbR) Rebecca L. Owen, Ph.D. Team Leader, Feed/Topical Team Division of Manufacturing Technologies ONADE/CVM/FDA Outline Background on CMC Filing Requirements What is QbR? QbR at

More information

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD Pharmaceutical Compounding Sterile and Nonsterile Preparations Jeanne Sun, PharmD Agenda Legal Framework Overview Pharmaceutical Compounding Nonsterile Preparations Pharmaceutical Compounding

More information

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION 21.3.2015 EN Official Journal of the European Union C 95/1 II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Guidelines of 19 March 2015 on

More information

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Trinity College Dublin QP Forum 2017 Tuesday 25 th April Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current

More information

The place of the Certification Procedure in the global regulatory environment

The place of the Certification Procedure in the global regulatory environment The place of the Certification Procedure in the global regulatory environment 19-20/09/2017 - Prague Workshop 1: how to build up a good CEP application Top ten deficiencies Cristian SAMPAOLESI Reference

More information

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC)

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC) Overview of USFDA Drug Regulatory Requirements Pharmaceutical Quality and Facility Inspections (GMP) Session II 19 February 2014 Casablanca, Morocco GMP The Other Side of Chemistry, Manufacturing & Controls

More information

Above & Beyond Quality

Above & Beyond Quality Above & Beyond Quality Science & Testing Quality Ingredients Manufacturing Excellence Natural, Organic & Non-GMO Vegetarian, Allergy-Friendly & Gluten-Free Products Manufacturing Location & Country of

More information

Perspectives on Method Validation: Importance of Adequate Method Validation

Perspectives on Method Validation: Importance of Adequate Method Validation Perspectives on Method Validation: Importance of Adequate Method Validation Heather Bridwell, Vikas Dhingra, Daniel Peckman, Jennifer Roark and Thomas Lehman The appropriate validation of analytical methods

More information

Compounding Pharmacy Assessment Questionnaire (CPAQ )

Compounding Pharmacy Assessment Questionnaire (CPAQ ) Compounding Pharmacy Assessment Questionnaire (CPAQ ) The International Academy of Compounding Pharmacists represents more than 2,700 pharmacists and other professionals who specialize in the provision

More information

On the Q&A to the Guideline for Common Technical Documents

On the Q&A to the Guideline for Common Technical Documents To: Public Health Bureau Prefectural Government Letter from PFSB/ELD 22 nd October 2001 From: Evaluation & Licensing Division, Pharmaceutical & Food Safety Bureau, The Ministry of Health, Labour and Welfare

More information

Thank You to United States Pharmacopeia for Their Sponsorship and Assistance

Thank You to United States Pharmacopeia for Their Sponsorship and Assistance Use of Measurement Uncertainty in Testing a Drug Substance M.L. Jane Weitzel Quality Analysis Consultants mljweitzel@msn.com Eurachem/CITAC Workshop June 2011 Thank You to United States Pharmacopeia for

More information

OOS: Back to Basics. Compliant, Effective, Efficient PATH

OOS: Back to Basics. Compliant, Effective, Efficient PATH OOS: Back to Basics Even with the number of trainings, seminars, online webinars and consultant guided investigations, companies are still seeing FDA 483 observations around how they are handling and investigating

More information

Documenta tion and Records

Documenta tion and Records Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping

More information

Guidelines for Preventing the Contamination of Feed Products with Toxic Substances

Guidelines for Preventing the Contamination of Feed Products with Toxic Substances Guidelines for Preventing the Contamination of Feed Products with Toxic Substances I. Purpose From the standpoint of the fundamental principle of prevention of adverse effects on the health of citizens

More information

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(6):88-98 Conduct of Inspections for Pharmaceutical Manufactures

More information

Guidance for Industry Process Validation: General Principles and Practices; A Contract Manufacturing Organization's Approach

Guidance for Industry Process Validation: General Principles and Practices; A Contract Manufacturing Organization's Approach May -3, 202 Javits Center New York, NY Guidance for Industry Process Validation: General Principles and Practices; A Contract Manufacturing Organization's Approach Sandra Lueken Director of Quality Baxter

More information

CGMP Requirements for Investigational Products

CGMP Requirements for Investigational Products PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health

More information

Quality Issues for Clinical Trial Materials: The Chemistry, Manufacturing and Controls (CMC) Review

Quality Issues for Clinical Trial Materials: The Chemistry, Manufacturing and Controls (CMC) Review Quality Issues for Clinical Trial Materials: The Chemistry, Manufacturing and Controls (CMC) Review Presented by Erika E. Englund, Ph.D. Slides courtesy of Dorota Matecka, Ph.D. Office of Pharmaceutical

More information

BIOPHARMACEUTICAL QUALITY. 18 July 2013 Cynthia H Sarnoski PhD

BIOPHARMACEUTICAL QUALITY. 18 July 2013 Cynthia H Sarnoski PhD BIOPHARMACEUTICAL QUALITY 18 July 2013 Cynthia H Sarnoski PhD What is Quality? 2 3 Quality Quality is never an accident; it is always the result of high intention, sincere effort, intelligent direction

More information

Session 4: Ensuring Product Quality Throughout the Supply Chain

Session 4: Ensuring Product Quality Throughout the Supply Chain Session 4: Ensuring Product Quality Throughout the Supply Chain Potential Quality Assurance Checkpoints Within the Overall Supply Chain 1. Raw Materials / Components 2. Manufacturing 3. Packaging 6. Receiving

More information

Quality Control in the Synthesis of Atorvastatin Calcium Secondary Reference Standard Kits Help Generic Manufacturers Minimize Impurities

Quality Control in the Synthesis of Atorvastatin Calcium Secondary Reference Standard Kits Help Generic Manufacturers Minimize Impurities Quality Control in the Synthesis of Atorvastatin Calcium Secondary Reference Standard Kits Help Generic Manufacturers Minimize Impurities by Steve Lane, NSF International When patent protection for Lipitor

More information

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction

More information

How to Identify Critical Quality Attributes and Critical Process Parameters

How to Identify Critical Quality Attributes and Critical Process Parameters How to Identify Critical Quality Attributes and Critical Process Parameters Jennifer Maguire, Ph.D. Daniel Peng, Ph.D. Office of Process and Facility (OPF) OPQ/CDER/FDA FDA/PQRI 2 nd Conference North Bethesda,

More information

18.H Questionnaire for preparing GMP-inspections

18.H Questionnaire for preparing GMP-inspections Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current

More information

Auditing Your Laboratory for Compliance with the FDA Dietary Supplement GMP s

Auditing Your Laboratory for Compliance with the FDA Dietary Supplement GMP s Tech Tip 0020 With the advent of the cgmp s, the majority of companies are increasing the frequency of their outsourced analytical testing. But the GMPs are just that, Good Manufacturing Practices, and

More information

WARNING LETTER AUG 3, 2016

WARNING LETTER AUG 3, 2016 Ropack, Inc. 8/3/16 Department of Health and Human Services Public Health Service Food and Drug Administration 10903 New Hampshire Avenue White Oak Building 66 Silver Spring, MD 20993 WARNING LETTER AUG

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS ANNEX 13 MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS Introduction Medicinal products intended for research and development trials are not at present subject either to marketing or manufacturing Community

More information

PHARMACEUTICAL AND BIOTECHNOLOGY UPDATE

PHARMACEUTICAL AND BIOTECHNOLOGY UPDATE Pharmaceutical and Biotechnology Update April 22, 2009 1 Hogan & Hartson LLP PHARMACEUTICAL AND BIOTECHNOLOGY UPDATE Current Trends in FDA s Pharmaceutical Good Manufacturing Practice (GMP) Warning Letters

More information

PHARMACEUTICAL AND BIOTECHNOLOGY UPDATE

PHARMACEUTICAL AND BIOTECHNOLOGY UPDATE Pharmaceutical and Biotechnology Update April 22, 2009 1 Hogan & Hartson LLP PHARMACEUTICAL AND BIOTECHNOLOGY UPDATE Current Trends in FDA s Pharmaceutical Good Manufacturing Practice (GMP) Warning Letters

More information

The Application of Pharmaceutical cgmp to Live Bacterial Products. James Harris Business Development Manager

The Application of Pharmaceutical cgmp to Live Bacterial Products. James Harris Business Development Manager The Application of Pharmaceutical cgmp to Live Bacterial Products James Harris Business Development Manager The Objective CMC expectations of a cgmp live bacterial biopharmaceutical project Overview Define

More information

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible

More information

Future of Question-based Review and Regulatory Submissions

Future of Question-based Review and Regulatory Submissions Future of Question-based Review and Regulatory Submissions Robert Iser Associate Director for Policy Development (Acting) Office of Pharmaceutical Science / CDER / FDA FDA/PQRI Conference on Evolving Product

More information

Post Approval Change Management Protocols/Comparability Protocols (PACMPs/CPs) Current and Future State

Post Approval Change Management Protocols/Comparability Protocols (PACMPs/CPs) Current and Future State Post Approval Change Management Protocols/Comparability Protocols (PACMPs/CPs) Current and Future State AAPS 2017 AM Sunrise Session Pramod Kotwal, Ph.D. Global Reg. Affairs Clinical Safety- CMC Policy

More information

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT API Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Part 1: General information Name of Manufacture Unit number

More information

STANDARD OPERATING PROCEDURES. Handling and working with Analytical Standards

STANDARD OPERATING PROCEDURES. Handling and working with Analytical Standards Page: 1 of 6 1.Purpose The purpose of this Standard Operating Procedure is to establish a standardized procedure of using United States Pharmacopoeia (USP) standards, detailing the procedure of qualification,

More information

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference

More information

INGREDIENTS, FOOD SUPPLEMENTS AND NUTRITIONAL

INGREDIENTS, FOOD SUPPLEMENTS AND NUTRITIONAL INGREDIENTS, FOOD SUPPLEMENTS AND NUTRITIONAL COMPOUNDS SAFETY: THE QUALITY CONTROL OF RAW MATERIALS IN NUTRACEUTICALS, TO PREVENT CONSUMER HEALTH RISK GRF00000883 00 Supplier qualification of nutraceutical

More information

The ABCs and Challenges of GMP The American Experience

The ABCs and Challenges of GMP The American Experience The ABCs and Challenges of GMP The American Experience The Canadian Association of Nuclear Medicine Toronto, Ontario April 22, 2017 Reiko Oyama, R.Ph., B.C.N.P. Washington University School of Medicine

More information

Hazard Analysis and Critical Control Point The Almond Board of California. Overview. Definitions

Hazard Analysis and Critical Control Point The Almond Board of California. Overview. Definitions Hazard Analysis and Critical Control Point The Almond Board of California Overview Hazard Analysis Critical Control Point (HACCP) is the final stage of an integrated, proactive food safety program targeting

More information

INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW

INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW International Journal of Pharmacy Review & Research www.ijprr.com INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW Vishal Sharma* and Nimrata Seth 1 Department of Pharmaceutics, Rayat Institute

More information

CHANGE CONTROL MANAGEMENT FOR A STABILITY PROGRAM

CHANGE CONTROL MANAGEMENT FOR A STABILITY PROGRAM Potential Changes and Minimizing the Impact of Registration CHANGE CONTROL MANAGEMENT FOR A STABILITY PROGRAM Kim Huynh Ba Eecutive Director PHARMALYTIK www.pharmalytik.com Biography Kim Huynh Ba has over

More information

JFS-A/B/C Standards <Manufacturing> [Interpretations]

JFS-A/B/C Standards <Manufacturing> [Interpretations] JFS-A/B/C Standards [Interpretations] JFS-A Standard Ver. 1.1 JFS-B Standard Ver. 1.1 JFS-C Standard Ver. 2.2 Japan Food Safety Management Association September 15, 2017 Table of Contents

More information

Enforcement of Compliance with GMPs in API manufacture

Enforcement of Compliance with GMPs in API manufacture Enforcement of Compliance with GMPs in API manufacture Guy Villax Copyright Hovione 2004 No one is more active in pharmaceutical ingredients Agenda What are APIs, GMP What is the legal framework What is

More information

Test item OECD guideline No 19

Test item OECD guideline No 19 Test item OECD guideline No 19 Advisory Document of the Working Group on Good Laboratory Practice on the Management, Characterisation and Use of Test Items sophie.svensson@swedac.se Agenda Background Definitions

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PH 1/97 (Rev. 3), 15 January 2002 ANNEX 15 QUALIFICATION AND

More information

GMP, GLP OR ISO 17025: HOW DO THESE APPLY TO OUTSOURCED ANALYTICAL TESTING?

GMP, GLP OR ISO 17025: HOW DO THESE APPLY TO OUTSOURCED ANALYTICAL TESTING? GMP, GLP OR ISO 17025: HOW DO THESE APPLY TO OUTSOURCED ANALYTICAL TESTING? Joe Grappin, MS, EAG Laboratories 2018 MD&M West Tech Theater 1 OVERVIEW Background: What Led to the Presentation History of

More information

Regulatory Aspects of Cleaning and Cleaning Validation. Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd.

Regulatory Aspects of Cleaning and Cleaning Validation. Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd. Regulatory Aspects of Cleaning and Cleaning Validation Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd. 28 June 2017 Why clean? Pharmaceutical production equipment is cleaned

More information

Analytical Method Transfer Program. Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP

Analytical Method Transfer Program. Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP Analytical Method Transfer Program Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP Outline Requirements for an AMT Program Develop Your AMT Program Qualify Your AMT Program On-going

More information